344 related articles for article (PubMed ID: 2464756)
1. Bone Gla protein messenger ribonucleic acid is regulated by both 1,25-dihydroxyvitamin D3 and 3',5'-cyclic adenosine monophosphate in rat osteosarcoma cells.
Theofan G; Price PA
Mol Endocrinol; 1989 Jan; 3(1):36-43. PubMed ID: 2464756
[TBL] [Abstract][Full Text] [Related]
2. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
[TBL] [Abstract][Full Text] [Related]
3. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of pertussis toxin-sensitive guanyl nucleotide-binding proteins increase parathyroid hormone receptors and reverse agonist-induced receptor down-regulation in ROS 17/2.8 cells.
Abou-Samra AB; Jueppner H; Potts JT; Segre GV
Endocrinology; 1989 Nov; 125(5):2594-9. PubMed ID: 2477233
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids and 1,25-dihydroxyvitamin D3 regulate parathyroid hormone stimulation of adenosine 3',5'-monophosphate-dependent protein kinase in rat osteosarcoma cells.
Titus L; Rubin JE; Lorang MT; Catherwood BD
Endocrinology; 1988 Sep; 123(3):1526-34. PubMed ID: 2456915
[TBL] [Abstract][Full Text] [Related]
6. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Spiess YH; Price PA; Deftos JL; Manolagas SC
Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells.
Klaus G; von Eichel B; May T; Hügel U; Mayer H; Ritz E; Mehls O
Endocrinology; 1994 Oct; 135(4):1307-15. PubMed ID: 7523093
[TBL] [Abstract][Full Text] [Related]
8. The effect of transcriptional inhibitors on the bone gamma-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells.
Pan LC; Price PA
J Biol Chem; 1984 May; 259(9):5844-7. PubMed ID: 6609159
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines.
Fraser JD; Otawara Y; Price PA
J Biol Chem; 1988 Jan; 263(2):911-6. PubMed ID: 3257212
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
11. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63.
Lajeunesse D; Kiebzak GM; Frondoza C; Sacktor B
Bone Miner; 1991 Sep; 14(3):237-50. PubMed ID: 1657256
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma inhibits 1,25-dihydroxyvitamin D3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanism.
Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood BD
Endocrinology; 1990 Aug; 127(2):588-94. PubMed ID: 2115429
[TBL] [Abstract][Full Text] [Related]
13. Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells.
Fraser JD; Price PA
Calcif Tissue Int; 1990 Apr; 46(4):270-9. PubMed ID: 2108798
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism.
Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood B
Endocrinology; 1991 May; 128(5):2577-82. PubMed ID: 2019266
[TBL] [Abstract][Full Text] [Related]
15. Evidence that stimulation of 1,25(OH)2D3 production in primary cultures of mouse kidney cells by cyclic AMP requires new protein synthesis.
Korkor AB; Gray RW; Henry HL; Kleinman JG; Blumenthal SS; Garancis JC
J Bone Miner Res; 1987 Dec; 2(6):517-24. PubMed ID: 2458676
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid and 1,25-dihydroxyvitamin D modulate the degree of adenosine 3',5'-monophosphate-dependent protein kinase isoenzyme I and II activation by parathyroid hormone in rat osteosarcoma cells.
Titus L; Rubin JE; Nanes MS; Catherwood BD
Endocrinology; 1989 Dec; 125(6):2806-11. PubMed ID: 2555128
[TBL] [Abstract][Full Text] [Related]
17. Cyclic adenosine 3',5'-monophosphate up-regulates 1,25-dihydroxyvitamin D3 receptor gene expression and enhances hormone action.
Krishnan AV; Feldman D
Mol Endocrinol; 1992 Feb; 6(2):198-206. PubMed ID: 1314957
[TBL] [Abstract][Full Text] [Related]
18. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T
Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744
[TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D3 and agents that increase intracellular adenosine 3',5'-monophosphate synergistically inhibit the mitogenic stimulation of human lymphocytes.
Ravid A; Koren R; Narinsky R; Rotem C; Novogrodsky A; Liberman A
J Clin Endocrinol Metab; 1990 Jun; 70(6):1687-92. PubMed ID: 1693374
[TBL] [Abstract][Full Text] [Related]
20. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs.
Farach-Carson MC; Sergeev I; Norman AW
Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
